A Phase 1 Open‐Label, Fixed‐Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects-Reference-Cited by-同舟云学术

A Phase 1 Open‐Label, Fixed‐Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects

Published:2021-05-05 Issue:11 Volume:10 Page:1279-1289
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Thai Ching¹,Tayo Bola¹,Critchley David¹

Affiliation:

1. GW Research Ltd Cambridge UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.950

Reference20 articles.

1. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

2. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

3. Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

4. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

5. Add‐on cannabidiol treatment for drugresistant seizures in tuberous sclerosis complex;Thiele E;JAMA Neurol,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review;Journal of Gastroenterology and Hepatology;2024-09-03

2. Metabolism and liver toxicity of cannabidiol;Journal of Environmental Science and Health, Part C;2024-06-21

3. Evaluation of potential drug–drug interactions with medical cannabis;Clinical and Translational Science;2024-05

4. Effects of cannabidiol and Δ ⁹ -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review;Drug Metabolism Reviews;2024-04-02

5. CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions;Pharmaceutics;2024-04-01